By determining that virus infection triggers the phosphorylation of MYH9 in two tyrosine residues essential for its proviral activity, and the family of non-receptor tyrosine kinases involved in this process, we may also provide new cellular targets to develop antiviral therapies. This evidence concerns the gene NTRK1 and viral infectious disease.